D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 105 Citations 47,762 552 World Ranking 3938 National Ranking 2232

Research.com Recognitions

Awards & Achievements

2012 - Distinguished Fellowship Award, American College of Cardiology (ACC)

2003 - Gifted Teacher Award, American College of Cardiology (ACC)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Gene

The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Pathology and Endocrinology. His research brings together the fields of Surgery and Internal medicine. As a part of the same scientific study, Prediman K. Shah usually deals with the Myocardial infarction, concentrating on Vulnerable plaque and frequently concerns with Mass screening.

His biological study spans a wide range of topics, including Inflammation, Thrombosis and Matrix metalloproteinase. His Endocrinology study integrates concerns from other disciplines, such as Apolipoprotein E and Neointima. Prediman K. Shah has included themes like Immunology, Aorta and Recombinant DNA in his Apolipoprotein B study.

His most cited work include:

  • Coronary Plaque Disruption (3063 citations)
  • From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I (2483 citations)
  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome (1421 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Cardiology, Myocardial infarction, Immunology and Endocrinology are his primary areas of study. Prediman K. Shah regularly links together related areas like Surgery in his Internal medicine studies. His work in Cardiology addresses subjects such as Anesthesia, which are connected to disciplines such as Stroke volume.

His Myocardial infarction study frequently links to related topics such as Radionuclide ventriculography. His Immunology research focuses on Apolipoprotein B and how it relates to Peptide, Apolipoprotein E and Vascular disease. His study looks at the relationship between Inflammation and topics such as Thrombosis, which overlap with Pathology and Thrombus.

He most often published in these fields:

  • Internal medicine (64.38%)
  • Cardiology (45.38%)
  • Myocardial infarction (24.83%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (64.38%)
  • Immunology (18.49%)
  • Cardiology (45.38%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Immunology, Cardiology, Endocrinology and Immune system. His Internal medicine study frequently draws parallels with other fields, such as Diabetes mellitus. In his study, which falls under the umbrella issue of Immunology, Adeno-associated virus, Aorta and Transplantation is strongly linked to Apolipoprotein E.

As part of his studies on Cardiology, he often connects relevant areas like Surgery. His Immune system study also includes

  • Atherosclerotic cardiovascular disease which is related to area like Cause of death and Pathophysiology,
  • Vaccination and related Disease. Prediman K. Shah interconnects Thrombosis, GATA3, Macrophage and Pathology in the investigation of issues within Inflammation.

Between 2011 and 2021, his most popular works were:

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome (1421 citations)
  • Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study (465 citations)
  • ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia (140 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Myocardial infarction

The scientist’s investigation covers issues in Internal medicine, Immune system, Immunology, Endocrinology and Cardiology. His work on Myocardial infarction, Cholesterol and Hazard ratio as part of general Internal medicine research is often related to Pressure overload, thus linking different fields of science. The Acute coronary syndrome and Unstable angina research Prediman K. Shah does as part of his general Myocardial infarction study is frequently linked to other disciplines of science, such as Adrenergic beta-Antagonists, therefore creating a link between diverse domains of science.

In his research, Apolipoprotein E is intimately related to Cytotoxic T cell, which falls under the overarching field of Immunology. While the research belongs to areas of Endocrinology, he spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Coronary atherosclerosis. His research links Adventitia with Cardiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Coronary Plaque Disruption

Erling Falk;Prediman K. Shah;Valentin Fuster.
Circulation (1995)

5017 Citations

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells.
Circulation (2003)

4582 Citations

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne.
The New England Journal of Medicine (2012)

2072 Citations

Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques Implications for Plaque Stabilization

Milita Crisby;Gunilla Nordin-Fredriksson;Prediman K. Shah;Juliana Yano.
Circulation (2001)

1490 Citations

From Vulnerable Plaque to Vulnerable Patient

Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells.
Circulation (2003)

1384 Citations

The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis

Timothy D. Henry;Brian H. Annex;George R. McKendall;Michael A. Azrin.
Circulation (2003)

1313 Citations

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Kathrin S. Michelsen;Michelle H. Wong;Prediman K. Shah;Wenxuan Zhang.
Proceedings of the National Academy of Sciences of the United States of America (2004)

1185 Citations

Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.

P K Shah;E Falk;J J Badimon;A Fernandez-Ortiz.
Circulation (1995)

1056 Citations

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study

J. Cohn;D. Archibald;S. Ziesche;J. Franciosa.
Survey of Anesthesiology (1987)

960 Citations

Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL

Xiaoou Helen Xu;Prediman K. Shah;Emmanuelle Faure;Ozlem Equils.
Circulation (2001)

837 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Prediman K. Shah

Valentin Fuster

Valentin Fuster

Icahn School of Medicine at Mount Sinai

Publications: 150

Stephen J. Nicholls

Stephen J. Nicholls

Monash University

Publications: 129

Peter Libby

Peter Libby

Brigham and Women's Hospital

Publications: 124

Jan Nilsson

Jan Nilsson

Lund University

Publications: 121

Zahi A. Fayad

Zahi A. Fayad

Icahn School of Medicine at Mount Sinai

Publications: 102

Patrick W. Serruys

Patrick W. Serruys

National University of Ireland, Galway

Publications: 98

Daniel J. Rader

Daniel J. Rader

University of Verona

Publications: 94

Göran K. Hansson

Göran K. Hansson

Karolinska University Hospital

Publications: 89

Chun Yuan

Chun Yuan

University of Washington

Publications: 87

Juan J. Badimon

Juan J. Badimon

Icahn School of Medicine at Mount Sinai

Publications: 84

Matthew J. Budoff

Matthew J. Budoff

UCLA Medical Center

Publications: 80

Renu Virmani

Renu Virmani

CVPath Institute

Publications: 79

Gerard Pasterkamp

Gerard Pasterkamp

Utrecht University

Publications: 76

Gerald F. Watts

Gerald F. Watts

University of Western Australia

Publications: 74

Philip J. Barter

Philip J. Barter

University of New South Wales

Publications: 73

Jean-Claude Tardif

Jean-Claude Tardif

Montreal Heart Institute

Publications: 69

Trending Scientists

steve simske

steve simske

Colorado State University

Arif Merchant

Arif Merchant

Google (United States)

Munchurl Kim

Munchurl Kim

Korea Advanced Institute of Science and Technology

Jose A. Antonino-Daviu

Jose A. Antonino-Daviu

Universitat Politècnica de València

Martin W. Brechbiel

Martin W. Brechbiel

National Institutes of Health

Igor L. Moudrakovski

Igor L. Moudrakovski

Max Planck Society

Kazuhiko Ishihara

Kazuhiko Ishihara

University of Tokyo

David C. Evers

David C. Evers

University of Minnesota

Niek N. Sanders

Niek N. Sanders

Ghent University

Emilio Salinas

Emilio Salinas

Wake Forest University

Martin Klein

Martin Klein

Vrije Universiteit Amsterdam

Linda Rose-Krasnor

Linda Rose-Krasnor

Brock University

Rick H. Hoyle

Rick H. Hoyle

Duke University

Gregory L. Burke

Gregory L. Burke

Wake Forest University

Colin Mathers

Colin Mathers

World Health Organization

Jaap Dronkers

Jaap Dronkers

Maastricht University

Something went wrong. Please try again later.